Lenvatinib With Taxane Drugs Treatment for Advanced Gastric Cancer
NCT05171530
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
19
Enrollment
OTHER
Sponsor class
Conditions
HER2-negative Advanced Gastric Cancer
Interventions
DRUG:
Lenvatinib plus taxane drugs
Sponsor
Ruijin Hospital